William D. Foulkes

ORCID: 0000-0001-7427-4651 · 6 papers in corpus
article 2026
·doi:10.1111/his.70155

Making a diagnosis of a rarely seen condition can be difficult for a pathologist, especially when key clinical and molecular observations are not available to them. We present an illustrative example. A 33-year-old woman presented to medica…

other 2025
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol32120675

Background: Endometriosis affects an estimated 10% of reproductive-aged women and is associated with increased ovarian cancer risk. While BRCA1/2 mutations are established risk factors for ovarian cancer, their association with endometriosi…

2025
Journal of Clinical Oncology ·doi:10.1200/jco.24.00176

PurposeIt is uncertain whether, and to what extent, hormonal contraceptives increase breast cancer (BC) risk for germline BRCA1 or BRCA2 mutation carriers.MethodsUsing pooled observational data from four prospective cohort studies, associat…

article 2025
·doi:10.1016/j.ijgc.2024.100355
2015
Current oncology (Toronto, Ont.) ·doi:10.3747/co.22.2588

BackgroundSarcomas in adults can be associated with hereditary cancer syndromes characterized by early-onset predisposition to numerous types of cancer. Because of variability in familial presentation and the largely unexplained genetic bas…

1993
British journal of cancer ·doi:10.1038/bjc.1993.101

Investigation of genetic changes in tumours by loss of heterozygosity (LOH) is a powerful technique for identifying chromosomal regions that may contain tumour suppressor genes. LOH has been described on chromosome 6 in ovarian carcinoma us…